CDK8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.809400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.617400E-01
Normal-vs-Stage2
8.927000E-01
Normal-vs-Stage3
1.457850E-02
Normal-vs-Stage4
1.254430E-01
Stage1-vs-Stage2
6.962600E-01
Stage1-vs-Stage3
1.582120E-02
Stage1-vs-Stage4
1.386400E-01
Stage2-vs-Stage3
6.972100E-02
Stage2-vs-Stage4
2.453700E-02
Stage3-vs-Stage4
4.221700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.927000E-01
Normal-vs-AfricanAmerican
7.690400E-01
Normal-vs-Asian
9.081600E-01
Caucasian-vs-AfricanAmerican
6.820400E-01
Caucasian-vs-Asian
7.478000E-01
AfricanAmerican-vs-Asian
9.174000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.422800E-01
Normal-vs-Female
9.841000E-01
Male-vs-Female
7.274800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.345600E-01
Normal-vs-Age(41-60Yrs)
5.979800E-01
Normal-vs-Age(61-80Yrs)
8.563200E-01
Normal-vs-Age(81-100Yrs)
9.630200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.757200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.774200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.884000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.210400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.917800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.831800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.884800E-01
Normal-vs-Daily Drinker
5.754400E-01
Normal-vs-Weekly Drinker
9.425800E-01
Normal-vs-Occasional Drinker
8.846200E-01
Normal-vs-Social Drinker
3.050400E-01
Non Drinker-vs-Daily Drinker
9.589800E-01
Non Drinker-vs-Weekly Drinker
4.881200E-01
Non Drinker-vs-Occasional Drinker
1.812170E-01
Non Drinker-vs-Social Drinker
1.252200E-01
Daily Drinker-vs-Weekly Drinker
4.971000E-01
Daily Drinker-vs-Occasional Drinker
1.930410E-01
Daily Drinker-vs-Social Drinker
1.245030E-01
Weekly Drinker-vs-Occasional Drinker
7.285400E-01
Weekly Drinker-vs-Social Drinker
3.278400E-01
Occasional Drinker-vs-Social Drinker
3.945200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.949600E-01
Normal-vs-Grade 2
1.487390E-01
Normal-vs-Grade 3
2.494000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.069000E-01
Grade 1-vs-Grade 3
4.670600E-01
Grade 1-vs-Grade 4
2.949600E-01
Grade 2-vs-Grade 3
8.675400E-01
Grade 2-vs-Grade 4
1.487390E-01
Grade 3-vs-Grade 4
2.494000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.742400E-01
Normal-vs-NonDiabetic
9.700600E-01
Diabetic-vs-NonDiabetic
2.960000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.838000E-01
Normal-vs-NoPancreatitis
8.484800E-01
Pancreatitis-vs-NoPancreatitis
3.014400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.382000E-01
Normal-vs-N1
9.323800E-01
N0-vs-N1
3.422000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.537400E-01
Normal-vs-TP53-NonMutant
8.490400E-01
TP53-Mutant-vs-TP53-NonMutant
6.906200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
